Open AccessSafety of cardiovascular magnetic resonance gadolinium chelates contrast agents in patients with hemoglobinopathies
Author(s) -
Antonella Meloni,
Brunella Favilli,
Vincenzo Positano,
Paolo Cianciulli,
Aldo Filosa,
Antonella Quarta,
Domenico Giuseppe D’Ascola,
Gennaro Restaino,
Massimo Lombardi,
Alessia Pepe
Publication year - 2009
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2009.010181
Subject(s) - gadolinium , magnetic resonance imaging , medicine , nephrogenic systemic fibrosis , gadolinium dtpa , chelation , myocardial fibrosis , contrast (vision) , chelation therapy , contrast enhancement , fibrosis , radiology , nuclear medicine , nuclear magnetic resonance , chemistry , thalassemia , artificial intelligence , computer science , physics , organic chemistry
doi:10.3324/haematol.2009.01018